- Title
- 371 - Should BMT Become a Certified Subspecialty? Results of the 2017 Board Certification Survey
- Creators
- Adriana K Malone - Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NYMark R Litzow - Division of Hematology, Mayo Clinic, Rochester, MNMiguel-Angel Perales - Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NYLuciano J Costa - Bone Marrow Transplantation and Cell Therapy Program, Division of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham Hospital, Birmingham, ALWilliam A Wood - Division of Hematology/Oncology, University of North Carolina, Chapel Hill, NCKrishna V Komanduri - Adult Stem Cell Transplant Program, University of Miami Hospital and Clinics, Sylvester Comprehensive Cancer Center, Miami, FLGeorge B Selby - Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OKShakila P Khan - Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MNVivek Roy - Division of Hematology, Mayo Clinic, Jacksonville, FLJennifer Domm - Division of Hematology/Oncology, Vanderbilt University, Nashville, TNLinda J Burns - National Marrow Donor Program/Be The Match, Minneapolis, MN
- Publication Details
- Biology of blood and marrow transplantation, Vol.24(3), pp.S305-S306
- Publisher
- Elsevier Inc
- Academic Unit
- Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
- Language
- English
- Resource Type
- Journal article
- Record Identifier
- 991031598738302976
Journal article
371 - Should BMT Become a Certified Subspecialty? Results of the 2017 Board Certification Survey
Biology of blood and marrow transplantation, Vol.24(3), pp.S305-S306
2018-03
Metrics
13 Record Views